Arcus Biosciences, Inc. RCUS

$19.10 -19.58% at last close

Recent SEC Filings

FormDescriptionFiledDocument
424B5 424B5 2026-10-21 View →
8-K 8-K 2026-10-21 View →
8-K 8-K 2026-10-20 View →
4 FORM 4 2026-08-24 View →
10-Q 10-Q 2026-08-05 View →
8-K 8-K 2026-08-05 View →
4 FORM 4 2026-07-13 View →
4 Insider transaction 2026-06-24 View →
4 FORM 4 2026-06-12 View →
4 FORM 4 2026-06-12 View →
4 FORM 4 2026-06-12 View →
4 FORM 4 2026-06-12 View →
4 FORM 4 2026-06-12 View →
4 FORM 4 2026-06-12 View →
4 FORM 4 2026-06-12 View →
4 FORM 4 2026-06-12 View →
8-K 8-K 2026-06-12 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-05-12 View →
4 FORM 4 2026-05-12 View →
10-Q 10-Q 2026-05-05 View →
8-K 8-K 2026-05-05 View →
DEF 14A DEF 14A 2026-04-21 View →
8-K 8-K 2026-04-20 View →
8-K 8-K 2026-03-23 View →
10-K 10-K 2026-02-25 View →
8-K 8-K 2026-02-25 View →
4 FORM 4 2026-01-26 View →
4 FORM 4 2026-01-26 View →
4 FORM 4 2026-01-26 View →
4 FORM 4 2026-01-26 View →
4 FORM 4 2026-01-26 View →
4 FORM 4 2026-01-26 View →
4 FORM 4 2026-01-26 View →
4 FORM 4 2026-01-09 View →
4 FORM 4 2026-01-07 View →
4 Insider transaction 2026-01-02 View →
4 Insider transaction 2026-01-02 View →
4 FORM 4 2025-12-18 View →
4 FORM 4 2025-12-18 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$19.10
Market Cap
$3.02 billion
52-Week Range
$11.68 – $31.73
Average Volume
1.97 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.